MOSUNETUZUMAB

MOSUNETUZUMAB was reported 1107 times

MOSUNETUZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATOBILIARY NEOPLASM 1 0.1000
1 T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0500
2 VASOGENIC CEREBRAL OEDEMA 31 0.0431
3 DNA MISMATCH REPAIR PROTEIN GENE MUTATION 1 0.0417
4 PERIPROSTHETIC JOINT INFECTION 1 0.0417
5 RESPIRATORY TRACT NEOPLASM 1 0.0417
6 SYNOVIAL FLUID ANALYSIS ABNORMAL 1 0.0303
7 DISSEMINATED NOCARDIOSIS 4 0.0288
8 URETERAL NEOPLASM 2 0.0256
9 FOLLICULAR LYMPHOMA RECURRENT 2 0.0250
10 FOLLICULAR LYMPHOMA 21 0.0239
11 OSTEOMYELITIS BACTERIAL 6 0.0219
12 TUMOUR FLARE 14 0.0205
13 ACETABULUM FRACTURE 7 0.0187
14 LOWER GASTROINTESTINAL PERFORATION 1 0.0169
15 URINARY TRACT NEOPLASM 1 0.0161
16 WRONG PRODUCT PROCURED 1 0.0152
17 CYTOKINE RELEASE SYNDROME 299 0.0149
18 ADENOVIRUS REACTIVATION 2 0.0139
19 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 28 0.0127
20 KLEBSIELLA TEST POSITIVE 8 0.0123
21 GENITOURINARY TRACT NEOPLASM 1 0.0120
22 LOWER RESPIRATORY TRACT INFLAMMATION 3 0.0112
23 SOFT TISSUE NEOPLASM 1 0.0076
24 RETICULOCYTOPENIA 1 0.0068
25 INTRA-ABDOMINAL PRESSURE INCREASED 1 0.0064
26 PNEUMONIA PARAINFLUENZAE VIRAL 1 0.0059
27 PNEUMONITIS CHEMICAL 2 0.0057
28 LYMPHOMA TRANSFORMATION 2 0.0056
29 B-CELL LYMPHOMA RECURRENT 3 0.0055
30 NEUROLOGICAL SYMPTOM 31 0.0054
31 MYCOTIC ENDOPHTHALMITIS 1 0.0053
32 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 30 0.0051
33 ADULT FAILURE TO THRIVE 1 0.0047
34 CITROBACTER INFECTION 2 0.0047
35 CYTOMEGALOVIRUS GASTROENTERITIS 1 0.0046
36 HYPOGAMMAGLOBULINAEMIA 27 0.0041
37 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 1 0.0039
38 HERPES ZOSTER REACTIVATION 1 0.0038
39 RESPIRATORY MONILIASIS 1 0.0037
40 EFFUSION 5 0.0037
41 GENITOURINARY TRACT INFECTION 1 0.0035
42 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
43 COVID-19 PNEUMONIA 41 0.0035
44 PROCALCITONIN INCREASED 4 0.0034
45 DUODENAL OBSTRUCTION 1 0.0033
46 ASPERGILLUS TEST POSITIVE 1 0.0032
47 INCARCERATED HERNIA 1 0.0032
48 BLOOD LACTATE DEHYDROGENASE DECREASED 1 0.0030
49 DIFFUSE LARGE B-CELL LYMPHOMA 23 0.0030
50 PULMONARY NECROSIS 1 0.0029
51 PSEUDOMONAL SEPSIS 5 0.0029
52 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
53 HUMAN RHINOVIRUS TEST POSITIVE 1 0.0027
54 MEDIASTINAL DISORDER 1 0.0027
55 INFLAMMATORY MARKER INCREASED 12 0.0024
56 PSEUDOMONAL BACTERAEMIA 2 0.0023
57 LYMPH GLAND INFECTION 1 0.0022
58 ANASTOMOTIC ULCER 1 0.0022
59 PNEUMONIA CRYPTOCOCCAL 2 0.0021
60 CYTOMEGALOVIRUS INFECTION REACTIVATION 9 0.0020
61 ENCEPHALITIS HERPES 1 0.0020
62 MYELOID LEUKAEMIA 1 0.0020
63 ORBITAL OEDEMA 1 0.0020
64 SPLENIC HAEMORRHAGE 1 0.0020
65 ENTEROCOCCAL BACTERAEMIA 2 0.0019
66 CORYNEBACTERIUM INFECTION 1 0.0019
67 THERAPY PARTIAL RESPONDER 29 0.0019
68 LYMPHOCYTOSIS 4 0.0019
69 URINARY TRACT INFECTION PSEUDOMONAL 1 0.0017
70 POST-ACUTE COVID-19 SYNDROME 2 0.0016
71 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
72 NECROTISING RETINITIS 1 0.0016
73 NOCARDIOSIS 4 0.0016
74 CHALAZION 1 0.0016
75 BONE OPERATION 1 0.0015
76 TUMOUR LYSIS SYNDROME 13 0.0015
77 DERMATITIS PSORIASIFORM 3 0.0015
78 IMMUNOGLOBULINS DECREASED 2 0.0015
79 FUSARIUM INFECTION 1 0.0014
80 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 1 0.0013
81 HERPES ZOSTER DISSEMINATED 1 0.0012
82 HAEMATOLOGICAL INFECTION 3 0.0012
83 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 1 0.0012
84 CAMPYLOBACTER INFECTION 1 0.0012
85 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
86 RETINITIS 2 0.0012
87 GASTROINTESTINAL NEOPLASM 1 0.0012
88 GASTROINTESTINAL FISTULA 1 0.0011
89 VASCULAR DEMENTIA 1 0.0011
90 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
91 DISEASE PROGRESSION 134 0.0011
92 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
93 PARVOVIRUS B19 INFECTION 1 0.0011
94 MUSCLE SWELLING 1 0.0011
95 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
96 HAEMOPHILUS INFECTION 1 0.0010
97 DILATED CARDIOMYOPATHY 1 0.0010
98 BREAST NEOPLASM 1 0.0010
99 ACINETOBACTER INFECTION 1 0.0009
100 OCULAR TOXICITY 1 0.0009
101 BLOOD FIBRINOGEN DECREASED 1 0.0009
102 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
103 LUMBAR VERTEBRAL FRACTURE 4 0.0009
104 INTERCEPTED MEDICATION ERROR 4 0.0009
105 ESCHERICHIA BACTERAEMIA 2 0.0008
106 STREPTOCOCCAL SEPSIS 1 0.0008
107 PNEUMONIA INFLUENZAL 1 0.0008
108 CHOLECYSTITIS 10 0.0008
109 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
110 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
111 ENCEPHALITIS VIRAL 1 0.0008
112 CYTOPENIA 10 0.0008
113 ORAL MUCOSA EROSION 1 0.0008
114 DISORIENTATION 32 0.0008
115 HERPES OPHTHALMIC 1 0.0008
116 GASTROENTERITIS NOROVIRUS 1 0.0008
117 RECURRENT CANCER 3 0.0007
118 ORAL FUNGAL INFECTION 2 0.0007
119 ALVEOLITIS 1 0.0007
120 PERIORBITAL SWELLING 4 0.0007
121 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
122 NEUTROPENIA 96 0.0007
123 POST HERPETIC NEURALGIA 1 0.0007
124 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
125 WRONG PATIENT RECEIVED PRODUCT 2 0.0007
126 PNEUMONITIS 18 0.0007
127 NEOPLASM SKIN 1 0.0006
128 HEPATITIS B REACTIVATION 2 0.0006
129 PNEUMONIA VIRAL 2 0.0006
130 CRYPTOCOCCOSIS 1 0.0006
131 SPLENIC RUPTURE 1 0.0006
132 SYSTEMIC INFECTION 1 0.0006
133 CYTOMEGALOVIRUS INFECTION 10 0.0006
134 SPLENOMEGALY 7 0.0006
135 NEOPLASM RECURRENCE 2 0.0006
136 INFARCTION 4 0.0006
137 OPHTHALMIC HERPES ZOSTER 1 0.0006
138 SOFT TISSUE INFECTION 1 0.0005
139 INTERVERTEBRAL DISCITIS 1 0.0005
140 BONE MARROW TRANSPLANT 1 0.0005
141 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
142 PNEUMONIA FUNGAL 2 0.0005
143 BACTERAEMIA 6 0.0005
144 BLOOD DISORDER 4 0.0005
145 CYSTITIS HAEMORRHAGIC 2 0.0005
146 CAPILLARY LEAK SYNDROME 1 0.0005
147 NEUTROPENIC COLITIS 1 0.0005
148 VARICELLA ZOSTER VIRUS INFECTION 1 0.0005
149 SUBILEUS 1 0.0005
150 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
151 OPTIC NEUROPATHY 1 0.0005
152 CD4 LYMPHOCYTES DECREASED 1 0.0005
153 PSEUDOMONAS INFECTION 4 0.0005
154 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
155 MALIGNANT NEOPLASM PROGRESSION 46 0.0004
156 SKIN INFECTION 5 0.0004
157 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
158 NEUTROPHIL COUNT DECREASED 18 0.0004
159 VASCULAR DEVICE INFECTION 2 0.0004
160 PUSTULE 1 0.0004
161 HAEMATOTOXICITY 4 0.0004
162 INJECTION SITE REACTION 28 0.0004
163 HYPOPHOSPHATAEMIA 3 0.0004
164 ORGANISING PNEUMONIA 2 0.0004
165 SYSTEMIC CANDIDA 1 0.0004
166 KLEBSIELLA INFECTION 2 0.0004
167 COVID-19 69 0.0004
168 ABDOMINAL INFECTION 1 0.0004
169 LYMPHOMA 6 0.0004
170 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
171 COMPARTMENT SYNDROME 1 0.0004
172 TONSILLITIS 2 0.0004
173 UVEITIS 5 0.0004
174 PLEURITIC PAIN 1 0.0004
175 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
176 NEUTROPHIL COUNT ABNORMAL 1 0.0004
177 PANCREATIC CARCINOMA METASTATIC 1 0.0004
178 NEOPLASM 4 0.0003
179 FEBRILE NEUTROPENIA 23 0.0003
180 ESCHERICHIA SEPSIS 1 0.0003
181 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
182 STRESS CARDIOMYOPATHY 2 0.0003
183 NEUROTOXICITY 6 0.0003
184 INFUSION RELATED REACTION 22 0.0003
185 CRANIOCEREBRAL INJURY 1 0.0003
186 PNEUMONIA BACTERIAL 3 0.0003
187 HYPERCALCAEMIA 4 0.0003
188 CHOLANGITIS 2 0.0003
189 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
190 LEUKOPENIA 16 0.0003
191 IRIDOCYCLITIS 1 0.0003
192 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
193 LIVER ABSCESS 1 0.0003
194 INJECTION SITE INFECTION 1 0.0003
195 THROMBOCYTOPENIA 34 0.0003
196 CORONAVIRUS INFECTION 2 0.0003
197 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
198 APLASIA PURE RED CELL 1 0.0003
199 LYMPHOEDEMA 2 0.0003
200 BRONCHIOLITIS 1 0.0003
201 NECROTISING FASCIITIS 1 0.0003
202 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
203 LYMPHOPENIA 4 0.0003
204 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
205 LIVER FUNCTION TEST INCREASED 6 0.0003
206 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
207 ANAPHYLACTIC SHOCK 7 0.0003
208 RASH MACULO-PAPULAR 6 0.0003
209 CARDIAC DYSFUNCTION 1 0.0003
210 BACTERIAL INFECTION 5 0.0003
211 HEPATIC FUNCTION ABNORMAL 10 0.0003
212 RASH PAPULAR 6 0.0003
213 HYDRONEPHROSIS 2 0.0003
214 CHEMOTHERAPY 1 0.0003
215 SEPTIC SHOCK 11 0.0003
216 ULCER 4 0.0003
217 OESOPHAGEAL CANDIDIASIS 1 0.0003
218 MYELOSUPPRESSION 9 0.0002
219 ARTERIOSPASM CORONARY 1 0.0002
220 RHINITIS 2 0.0002
221 ENURESIS 1 0.0002
222 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
223 SHOCK HAEMORRHAGIC 2 0.0002
224 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
225 PERIPHERAL VENOUS DISEASE 1 0.0002
226 HYPERURICAEMIA 1 0.0002
227 ESCHERICHIA INFECTION 2 0.0002
228 GASTROINTESTINAL PERFORATION 1 0.0002
229 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
230 HYPERPYREXIA 1 0.0002
231 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
232 METASTATIC NEOPLASM 1 0.0002
233 NEOPLASM PROGRESSION 8 0.0002
234 HYPOXIA 8 0.0002
235 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
236 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
237 HEPATOTOXICITY 5 0.0002
238 ILEUS PARALYTIC 1 0.0002
239 SUSPECTED OFF LABEL USE 1 0.0002
240 OSTEOMYELITIS 4 0.0002
241 LOCALISED OEDEMA 1 0.0002
242 ARTHRITIS INFECTIVE 1 0.0002
243 DEEP VEIN THROMBOSIS 14 0.0002
244 RENAL FUNCTION TEST ABNORMAL 1 0.0002
245 AGRANULOCYTOSIS 4 0.0002
246 PERFORMANCE STATUS DECREASED 1 0.0002
247 APPENDICITIS 2 0.0002
248 CHOLELITHIASIS 7 0.0002
249 PYREXIA 72 0.0002
250 ENTEROCOCCAL INFECTION 1 0.0002
251 GUILLAIN-BARRE SYNDROME 1 0.0002
252 ENCEPHALOPATHY 5 0.0002
253 LIVER DISORDER 9 0.0002
254 STAPHYLOCOCCAL SEPSIS 1 0.0002
255 SKIN EXFOLIATION 17 0.0002
256 INFECTION 29 0.0002
257 RASH MACULAR 7 0.0002
258 DERMATITIS EXFOLIATIVE 1 0.0002
259 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
260 ERYSIPELAS 1 0.0002
261 PATHOLOGICAL FRACTURE 1 0.0002
262 DRUG RESISTANCE 5 0.0002
263 SKIN NECROSIS 1 0.0002
264 FAILURE TO THRIVE 1 0.0002
265 SERUM FERRITIN INCREASED 1 0.0002
266 RASH ERYTHEMATOUS 9 0.0002
267 COMPRESSION FRACTURE 1 0.0002
268 MELAENA 4 0.0002
269 STREPTOCOCCAL INFECTION 1 0.0002
270 ACUTE PULMONARY OEDEMA 1 0.0002
271 BLOOD URIC ACID INCREASED 1 0.0002
272 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
273 DRUG ERUPTION 3 0.0002
274 HEPATITIS B 1 0.0002
275 HEPATIC FAILURE 5 0.0002
276 PLATELET COUNT ABNORMAL 1 0.0002
277 MENISCUS INJURY 1 0.0002
278 SMALL INTESTINAL OBSTRUCTION 2 0.0002
279 PANCYTOPENIA 9 0.0002
280 NERVOUS SYSTEM DISORDER 5 0.0002
281 SWELLING OF EYELID 1 0.0002
282 CELLULITIS 8 0.0002
283 PNEUMONIA 51 0.0002
284 NO ADVERSE EVENT 28 0.0002
285 HERPES SIMPLEX 1 0.0002
286 HEPATITIS ACUTE 1 0.0002
287 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
288 PRODUCT PREPARATION ISSUE 1 0.0002
289 ASPERGILLUS INFECTION 1 0.0002
290 RESPIRATORY FAILURE 11 0.0002
291 CARDIAC FAILURE ACUTE 1 0.0001
292 MENINGITIS 1 0.0001
293 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
294 COLITIS ISCHAEMIC 1 0.0001
295 PLEURAL EFFUSION 9 0.0001
296 BODY TEMPERATURE INCREASED 3 0.0001
297 JOINT EFFUSION 1 0.0001
298 CHILLS 17 0.0001
299 HYPERTRANSAMINASAEMIA 1 0.0001
300 SEPSIS 16 0.0001
301 EXTRASYSTOLES 1 0.0001
302 APPLICATION SITE REACTION 1 0.0001
303 PULMONARY TOXICITY 1 0.0001
304 NEUTROPENIC SEPSIS 1 0.0001
305 GRAFT VERSUS HOST DISEASE 1 0.0001
306 C-REACTIVE PROTEIN INCREASED 5 0.0001
307 HYPERGLYCAEMIA 5 0.0001
308 GASTROENTERITIS 2 0.0001
309 ASCITES 4 0.0001
310 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
311 TRANSAMINASES INCREASED 3 0.0001
312 COLON CANCER 2 0.0001
313 ATRIAL FIBRILLATION 13 0.0001
314 ATRIOVENTRICULAR BLOCK 1 0.0001
315 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
316 PULMONARY HAEMORRHAGE 1 0.0001
317 AFFECTIVE DISORDER 1 0.0001
318 NEUROPATHY PERIPHERAL 12 0.0001
319 RENAL CYST 1 0.0001
320 INTERSTITIAL LUNG DISEASE 6 0.0001
321 HERPES ZOSTER 7 0.0001
322 SPINAL COMPRESSION FRACTURE 1 0.0001
323 EMBOLISM 1 0.0001
324 SECOND PRIMARY MALIGNANCY 1 0.0001
325 FUNGAL INFECTION 4 0.0001
326 PERICARDITIS 2 0.0001
327 HEPATIC ENZYME INCREASED 8 0.0001
328 PYELONEPHRITIS 1 0.0001
329 URINE OUTPUT DECREASED 1 0.0001
330 IMMUNOSUPPRESSION 1 0.0001
331 CARDIOTOXICITY 1 0.0001
332 GASTROINTESTINAL INFECTION 1 0.0001
333 MYOSITIS 1 0.0001
334 SYNOVITIS 2 0.0001
335 RETINAL DETACHMENT 1 0.0001
336 UROSEPSIS 1 0.0001
337 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
338 PERSONALITY CHANGE 1 0.0001
339 INFLUENZA 12 0.0001
340 BLOOD CREATININE INCREASED 7 0.0001
341 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
342 ATELECTASIS 1 0.0001
343 RASH 44 0.0001
344 HYPOTONIA 1 0.0001
345 HYPERBILIRUBINAEMIA 1 0.0001
346 ANAEMIA 18 0.0001
347 DECREASED ACTIVITY 1 0.0001
348 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
349 SKIN DISORDER 3 0.0001
350 MALNUTRITION 1 0.0001
351 INTESTINAL PERFORATION 1 0.0001
352 OXYGEN SATURATION DECREASED 5 0.0001
353 FISTULA 1 0.0001
354 EYE INFECTION 1 0.0001
355 OFF LABEL USE 77 0.0001
356 DELIRIUM 3 0.0001
357 ELECTROLYTE IMBALANCE 1 0.0001
358 VASCULITIS 1 0.0001
359 BONE PAIN 5 0.0001
360 LYMPHADENOPATHY 3 0.0001
361 PLATELET COUNT DECREASED 9 0.0001
362 PRODUCT PRESCRIBING ERROR 2 0.0001
363 POLYNEUROPATHY 1 0.0001
364 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
365 CEREBRAL INFARCTION 2 0.0001
366 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
367 GENERALISED OEDEMA 1 0.0001
368 PHARYNGITIS 1 0.0001
369 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
370 SKIN ULCER 2 0.0001
371 INJECTION SITE INDURATION 1 0.0001
372 ORAL CANDIDIASIS 1 0.0001
373 SARS-COV-2 TEST POSITIVE 1 0.0001
374 HYPOTENSION 15 0.0001
375 DIVERTICULITIS 2 0.0001
376 HEPATOCELLULAR INJURY 1 0.0001
377 CARDIOGENIC SHOCK 1 0.0001
378 MYELODYSPLASTIC SYNDROME 1 0.0001
379 HYPERTHYROIDISM 1 0.0001
380 MENTAL DISORDER 3 0.0001
381 FLUID OVERLOAD 1 0.0001
382 HAEMORRHAGE INTRACRANIAL 1 0.0001
383 DEVICE RELATED INFECTION 1 0.0001
384 TENDONITIS 1 0.0001
385 ACUTE MYELOID LEUKAEMIA 1 0.0001
386 BRAIN FOG 1 0.0001
387 ARRHYTHMIA 3 0.0001
388 HEAD INJURY 2 0.0001
389 HALLUCINATION, AUDITORY 1 0.0001
390 NIGHT SWEATS 2 0.0001
391 MUSCLE TIGHTNESS 1 0.0001
392 LUNG DISORDER 3 0.0001
393 STAPHYLOCOCCAL INFECTION 2 0.0001
394 VENTRICULAR TACHYCARDIA 1 0.0001
395 DEATH 52 0.0001
396 DRY SKIN 8 0.0001
397 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
398 CANDIDA INFECTION 1 0.0001
399 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
400 HEMIPARESIS 1 0.0001
401 URINARY TRACT INFECTION 10 0.0001
402 ORTHOSTATIC HYPOTENSION 1 0.0001
403 EOSINOPHILIA 1 0.0001
404 LYMPHOCYTE COUNT DECREASED 1 0.0001
405 ISCHAEMIC STROKE 1 0.0001
406 RASH PRURITIC 3 0.0001
407 HYPONATRAEMIA 3 0.0001
408 HEPATIC CIRRHOSIS 1 0.0001
409 COLITIS 2 0.0001
410 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
411 ACUTE RESPIRATORY FAILURE 1 0.0001
412 DRUG INTOLERANCE 5 0.0001
413 HAEMATOCRIT DECREASED 1 0.0001
414 DERMATITIS 1 0.0000
415 HALLUCINATION, VISUAL 1 0.0000
416 DECREASED APPETITE 11 0.0000
417 SKIN CANCER 1 0.0000
418 PRODUCT PRESCRIBING ISSUE 1 0.0000
419 ACUTE KIDNEY INJURY 7 0.0000
420 PRODUCT STORAGE ERROR 4 0.0000
421 ANGIOEDEMA 2 0.0000
422 BLOOD PRESSURE DECREASED 3 0.0000
423 PULMONARY OEDEMA 2 0.0000
424 THERAPY NON-RESPONDER 2 0.0000
425 PANCREATITIS ACUTE 1 0.0000
426 MUSCULAR WEAKNESS 5 0.0000
427 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
428 PRODUCT AVAILABILITY ISSUE 1 0.0000
429 NEPHROLITHIASIS 2 0.0000
430 SHOCK 1 0.0000
431 PERICARDIAL EFFUSION 1 0.0000
432 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
433 COGNITIVE DISORDER 2 0.0000
434 CARDIAC DISORDER 4 0.0000
435 PULMONARY EMBOLISM 4 0.0000
436 MENTAL IMPAIRMENT 1 0.0000
437 PNEUMONIA ASPIRATION 1 0.0000
438 HEPATITIS 1 0.0000
439 ERYTHEMA 8 0.0000
440 INFLAMMATION 2 0.0000
441 ABDOMINAL PAIN 9 0.0000
442 RESPIRATORY TRACT INFECTION 1 0.0000
443 MUCOSAL INFLAMMATION 1 0.0000
444 BRADYCARDIA 2 0.0000
445 CARDIAC FAILURE 3 0.0000
446 DISTURBANCE IN ATTENTION 2 0.0000
447 SKIN LESION 1 0.0000
448 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
449 CARDIAC ARREST 3 0.0000
450 TREATMENT FAILURE 3 0.0000
451 ANAPHYLACTIC REACTION 2 0.0000
452 TREMOR 6 0.0000
453 MENTAL STATUS CHANGES 1 0.0000
454 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
455 DEMENTIA 1 0.0000
456 WOUND 1 0.0000
457 RENAL IMPAIRMENT 3 0.0000
458 RED BLOOD CELL COUNT DECREASED 1 0.0000
459 MUSCULOSKELETAL STIFFNESS 3 0.0000
460 DYSPHONIA 2 0.0000
461 PALPITATIONS 4 0.0000
462 TACHYCARDIA 3 0.0000
463 RESPIRATORY DISORDER 1 0.0000
464 JOINT SWELLING 4 0.0000
465 THERAPEUTIC RESPONSE DECREASED 2 0.0000
466 STOMATITIS 2 0.0000
467 EPILEPSY 1 0.0000
468 INJECTION SITE RASH 1 0.0000
469 INJECTION SITE ERYTHEMA 4 0.0000
470 DRUG-INDUCED LIVER INJURY 1 0.0000
471 CYSTITIS 1 0.0000
472 HIP FRACTURE 1 0.0000
473 FATIGUE 24 0.0000
474 SWELLING FACE 2 0.0000
475 OSTEONECROSIS 1 0.0000
476 VIRAL INFECTION 1 0.0000
477 SYNCOPE 3 0.0000
478 URINARY RETENTION 1 0.0000
479 GAIT INABILITY 1 0.0000
480 INJURY 2 0.0000
481 DYSPNOEA 16 0.0000
482 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
483 CEREBRAL HAEMORRHAGE 1 0.0000
484 SKIN BURNING SENSATION 2 0.0000
485 BRONCHITIS 2 0.0000
486 CHEST PAIN 5 0.0000
487 HYPOAESTHESIA 4 0.0000
488 ASTHENIA 10 0.0000
489 DYSPNOEA EXERTIONAL 1 0.0000
490 INTESTINAL OBSTRUCTION 1 0.0000
491 HEADACHE 16 0.0000
492 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
493 CARDIAC FAILURE CONGESTIVE 2 0.0000
494 CONFUSIONAL STATE 4 0.0000
495 LUNG NEOPLASM MALIGNANT 1 0.0000
496 RHABDOMYOLYSIS 1 0.0000
497 HYPOACUSIS 1 0.0000
498 BALANCE DISORDER 2 0.0000
499 DEHYDRATION 3 0.0000
500 MEMORY IMPAIRMENT 3 0.0000
501 NASOPHARYNGITIS 4 0.0000
502 HYPOKALAEMIA 1 0.0000
503 VOMITING 10 0.0000
504 COMA 1 0.0000
505 COLORECTAL CANCER 1 0.0000
506 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
507 DIARRHOEA 13 0.0000
508 CHEST DISCOMFORT 2 0.0000
509 THERAPY CESSATION 1 0.0000
510 HAEMOGLOBIN DECREASED 2 0.0000
511 ECZEMA 1 0.0000
512 DRUG INEFFECTIVE 25 0.0000
513 OEDEMA 1 0.0000
514 PRURITUS 7 0.0000
515 URTICARIA 3 0.0000
516 BLISTER 1 0.0000
517 NAUSEA 14 0.0000
518 MYALGIA 3 0.0000
519 LETHARGY 1 0.0000
520 SEIZURE 2 0.0000
521 MYOCARDIAL INFARCTION 3 0.0000
522 ILL-DEFINED DISORDER 1 0.0000
523 VERTIGO 1 0.0000
524 DISCOMFORT 1 0.0000
525 HYPERSENSITIVITY 3 0.0000
526 PRODUCT USE ISSUE 3 0.0000
527 AMNESIA 1 0.0000
528 RENAL FAILURE 2 0.0000
529 ABDOMINAL PAIN UPPER 3 0.0000
530 VISION BLURRED 2 0.0000
531 HYPERTENSION 3 0.0000
532 CONSTIPATION 3 0.0000
533 MALAISE 6 0.0000
534 AGITATION 1 0.0000
535 DYSGEUSIA 1 0.0000
536 HALLUCINATION 1 0.0000
537 CONDITION AGGRAVATED 4 0.0000
538 INJECTION SITE SWELLING 1 0.0000
539 PAIN 8 0.0000
540 PARAESTHESIA 2 0.0000
541 PROSTATE CANCER 1 0.0000
542 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
543 INFLUENZA LIKE ILLNESS 1 0.0000
544 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
545 ARTHRALGIA 5 0.0000
546 FALL 4 0.0000
547 COMPLETED SUICIDE 1 0.0000
548 TOXICITY TO VARIOUS AGENTS 2 0.0000
549 CEREBROVASCULAR ACCIDENT 2 0.0000
550 GASTROINTESTINAL DISORDER 1 0.0000
551 ADVERSE DRUG REACTION 1 0.0000
552 OROPHARYNGEAL PAIN 1 0.0000
553 BREAST CANCER 1 0.0000
554 COUGH 3 0.0000
555 ALOPECIA 2 0.0000
556 HEART RATE INCREASED 1 0.0000
557 DIZZINESS 5 0.0000
558 SOMNOLENCE 2 0.0000
559 SINUSITIS 1 0.0000
560 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
561 ABDOMINAL DISTENSION 1 0.0000
562 HAEMORRHAGE 1 0.0000
563 ASTHMA 1 0.0000
564 FEELING ABNORMAL 2 0.0000
565 OEDEMA PERIPHERAL 1 0.0000
566 LOSS OF CONSCIOUSNESS 1 0.0000
567 WEIGHT DECREASED 2 0.0000
568 ANXIETY 2 0.0000
569 PAIN IN EXTREMITY 2 0.0000
570 GAIT DISTURBANCE 1 0.0000
571 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
572 WEIGHT INCREASED 1 0.0000
573 DEPRESSION 1 0.0000
574 INCORRECT DOSE ADMINISTERED 1 0.0000
575 INSOMNIA 1 0.0000
576 PRODUCT DOSE OMISSION ISSUE 1 0.0000
577 INJECTION SITE PAIN 1 0.0000